The Medical Advisor

The common denominator for overall health—including longevity, brain health, gut health, liver health, immune health, and kidney health—is mitochondrial health. Many chronic diseases can be traced to mitochondrial dysfunction. Seemingly diverse conditions—including  diabetes ,  hypertension ,  heart disease ,  cancer , allergies, autoimmune diseases such as rheumatoid arthritis, and even various mental illnesses—can be understood through a “unified theory” of mitochondrial imbalance. Mitochondria are involved in many vital processes in human cells, including energy production, fatty-acid oxidation, and the Tricarboxylic Acid (TCA) cycle, calcium signaling, apoptosis (cellular death), and heat production. However to simplify things let’s talk about energy and longevity which is what their function translates to for practical purposes. And to help this occur, we can review the health practices, along with the best supplements to improve mitocho...

Quick answer: Mounjaro and Zepbound contain the same active ingredient, tirzepatide . Ozempic and Wegovy contain the same active ingredient, semaglutide . The major pharmacological difference is that tirzepatide activates both the GIP and GLP-1 receptors , while semaglutide primarily activates the GLP-1 receptor . For people specifically seeking obesity treatment, direct head-to-head evidence favors tirzepatide for average weight loss. However, the "best" medication is not determined by weight loss alone. Diabetes status, cardiovascular or kidney disease, obstructive sleep apnea, side effects, contraindications, access, cost, and treatment goals all matter. Mounjaro, Ozempic, Wegovy, and Zepbound are among the most discussed medications in modern obesity and metabolic medicine. They are often grouped together as "GLP-1 drugs," but that description is incomplete. Two different molecules are involved: Semaglutide: Ozempic and Wegovy Tirzepatide: Moun...